SEB Asset Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.6M Buy
90,679
+369
+0.4% +$73.1K 0.07% 228
2026
Q2
$16.9M Buy
90,310
+20,680
+30% +$3.02M 0.06% 253
2026
Q1
$6.77M Buy
+69,630
New +$7.03M 0.03% 397

Other funds holding RVMD

SEB Asset Management's RVMD Position: Q3 2026 in Review

SEB Asset Management increased its Revolution Medicines (RVMD) stake by 0.41% in Q3 2026, buying an estimated $73.1K and bringing the position to 90,679 shares worth $18.6M. The position accounts for 0.07% of the portfolio, ranked #228.

SEB Asset Management first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. 760 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • SEB Asset Management held 90,679 shares of Revolution Medicines worth $18.6M as of Q3 2026.
  • SEB Asset Management bought 369 Revolution Medicines shares in Q3 2026, an estimated $73.1K.
  • Revolution Medicines made up 0.07% of SEB Asset Management's portfolio in Q3 2026, its #228 holding.
  • SEB Asset Management first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
  • 760 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.